This session introduces the pharmacological basis of angiotensin-converting enzyme (ACE) inhibitors, building upon the physiological foundation of the renin–angiotensin–aldosterone system (RAAS). We will examine their mechanism of action, general pharmacodynamic and pharmacokinetic properties, and their broad therapeutic applications in cardiovascular and renal medicine. Emphasis will be placed on understanding the rationale for ACE inhibitor use in various clinical settings, rather than on memorizing individual drug profiles. Learning Objectives: By the end of this lecture, participants should be able to: Explain the mechanism of action of ACE inhibitors in the context of the RAAS pathway. Identify the major physiological and clinical effects resulting from ACE inhibition. List the primary therapeutic indications for ACE inhibitors, including cardiovascular and renal conditions. Recognize the role of ACE inhibitors in reducing morbidity and mortality in key disease states.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 7604 Elderwood Court
Pricing
CME included with membership
| Lifetime Access | $67 |
| Individual Course (entry-level) | $20 |
| Individual Course (standard) | $25 |
| Individual Course (advanced) | $45 |
| Individual Course (premium) | $650 |
| Free Course | Free |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiothoracic Surgery
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Facial Plastic & Reconstructive Surgery
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Hematology
- Infectious Disease
- Interventional Cardiology
- Medical Microbiology
- Medical Oncology
- Medical Toxicology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Neurosurgery
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Pediatric Cardiology
- Pediatric Gastroenterology
- Pediatric Neurology
- Pediatric Surgery
- Physical Medicine & Rehabilitation
- Plastic & Reconstructive Surgery
- Primary Care Sports Medicine
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Spine Surgery
- Surgery of the Hand & Upper Extremity
- Trauma Surgery
- Urology
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Membership pricing — $20–650
This provider prices CME through membership. Individual courses may also be sold separately.
Free membership available for some groups
See plans on members.drbeen.comListed by the provider · members.drbeen.com
- On-demand / recorded video
- Credit · Up to 0.75 credits
- Membership pricing
-
ReleasedNov 18, 2025
-
Last day to claim creditNov 18, 2028 2 years left
-
Advancing Kidney Health through Optimal Medication Management (AKHOMM) +1 AKHOMM: Clinical Approach and Emerging Therapeutics for Focal Segmental Glomerulosclerosis (FSGS)
-
Clinical Care Options, LLC (dba Decera Clinical Education) Arm-in-Arm With Heart Failure Experts: A Master Class in Optimizing Heart Failure Treatment With SGLT2 Inhibitors
-
PRIME Education, Inc. (PRIME®) Maximizing Outcomes in PAH: Targeted Therapies and Evidence-Based Treatment Strategies
